FDMT

News 4dMT Revenue Jumps 200 Percent in Q2

14d ago

News 4D Molecular Therapeutics tumbles following mid-stage clinical study results - Investing.com

14d ago

News 4d Molecular Therapeutics CEO sells $290k in stock - Investing.com

14d ago

News 4D Molecular Therapeutics officer sells $90,757 in stock By Investing.com - Investing.com Australia

14d ago

News Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts

14d ago

News Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside

14d ago

Insider trade Sale by Ashoo Gupta (VP, Finance and Controller)

69d ago

SEC filing FDMT Reports $118M Cash Raise, $514M Balance Sheet, 4FRONT-1 Enrollment Complete, Topline Data H1 2027

75d ago

News BHM 2025 Tax Reporting Information For 2025 Dividends

123d ago

News US Stocks Climb as Markets Eye Tech Earnings, Fed Meeting | Closing Bell

126d ago

News 4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

153d ago

News 4DMT Appoints Kristian Humer as Chief Financial Officer

155d ago

News Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely

156d ago

Scanner Unusual volume (z=4.2)

160d ago

Scanner Unusual volume (z=4.5)

161d ago

Scanner Unusual volume (z=4.5)

163d ago

Scanner Unusual volume (z=4.5)

164d ago

Scanner Unusual volume (z=6.5)

165d ago

Short volume Short volume 53% of volume (5.6σ)

168d ago